Study of the relationship between the level of angiotensinogen hormone and other vital variables with stage of nephropathy in type II diabetic patients
DOI:
https://doi.org/10.36320/ajb/v10.i3.8108Keywords:
Diabetic mellitus, nephropath, angiotensinogenAbstract
Diabetes mellitus is the most common worldwide disease and one of its important complications is diabetic nephropathy. The activation of renin- angiotensin - aldosterone system (RAAS) is an important mediator of diabetic nephropathy. Urinary angiotensinogen, a novel biomarker of the intrarenal RAAS, is associated with the development of kidney damage. Therefore, the current study investigated the determinants of urinary angiotensinogen and its associations with staging of diabetic nephropathy and the early detection on some changes in kidney functions as result of diabetic disorder.
Downloads
References
AL Kakrani, G. V. S.; VohraKaran V. and Chaudhary N. ( 2014 ). Clinical and Nerve Conduction Study Correlation in Patients of Diabetic Neuropathy. J. Associat. Phys. Ind., 62:24-27.
Tripathi, B. K. and Srivastava, A. K. (2006). Diabetes mellitus Complications and therapeutics. Med. Sci. Monit., 12(7):130-
Pryor W. ( 2000 ). Vitamin E and heart disease : basic science to clinical intervention trials , Free Rad Biol. Med., 28:141-164.
Johnson, F. and Giulivi C. ( 2005 ). Superoxide dismutase and their impact upon human health. Mol. Aspects Med. (2005)26: 340 – 245.
Long – acting exenatide for the treatment of type 2 diabetes . Nat. Insti. Heal. Clin. Ex., 2011.
Bener, A.; Zirie, M.; Janahi, I. M.; Al-Hamaq, A. O.; Musallam, M. and Wareham , N . J . ( 2009 ) . Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diabet . Res. And clin. Pract., 84(1),99-106.
Fowler, M. J. ( 2007 ). Diabetes: magnitude and mechanisms. Clin. Diabet., 25:25-8.
Rewers, M. ( 2002 ). Type 1 diabetes mellitus: epidemiology, genetics, pathogenesis and clinical manifestations. In Poretsky, L. (ed) , principles of diabetes mellitus. Boston, Kluwer Academic Publishers .
Wild , S.; Roglic, G .; Green , A.; Sicree, R . and King, H. ( 2004 ) . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabet. Care.May., 27(5): 1047-53.
Ciampelli, M.; Leoni, F. and Cucinelli, F.( 2005). Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients. J. Clin. End Met. ,90(3):1398-1406.
Gitanjali ; Block, T .; Bagh, R. and Santacruz, A. ( 2011 ). Glycosylated hemoglobin(GHb) The marker for retrospective glycemic control . TULIP Group .
Jha, P.; Das, B. K. L.; Shrestha S.; Majhi, S.; Chandra , l.; Sharma, S. and Baral , N .( 2010 ) . Glycemic status, lipid profile and proteinuria in diabetic nephropathy. J. Nepal. Med. Assoc., 49 (178 ):143-149.
Rema, M. and Pradeepa R. Indian Med. J. Res. ( 2007 ) ;125:297-310.
uepet, F. H.; Agaba, E. and Chuhwak, C. ( 2003 ). Some metabolic abnormalities in type 2 diabetes in Jos, north central Nigeria Nig. J. Med., 12:193-197.
Singh, D. k. and Farrington, K. ( 2010 ). The tubulointerstium in early diabetic nephropathy. Int. J. Diabet. In Developing countries., 30(4):185-190.
Ailhaud, G.; Fukamizu, A.; Massiera, F.; Negrel, R.; Saint- Marc, P. and Teboul, M. ( 2000 ). Angiotensinogen, angiotensin II and adipose tissue development. Inter. J.Obes., 24(4): S33-S35.
Jonsson, J. R.; Game, P. A.; Head, R. J.; Frewin, D. B. (1994). The expression and localization of the angiotensin-converting enzyme mRNA in human adipose tissue. Blood . Pressure ., 3:72 - 75.
Fiseha, T.; ( 2015 ). Urinary biomarkers for early diabetic Nephropathy in type 2 diabetic patients. Fiseha . Biomark. Res, 3(16):1-7.
Han, T.; Sattar, N. & Lean, M. (2006). ABC of obesity. Assessment of obesity and its clinical implications. Brit. Med. J., 333:695-698.
Schmidtz, A. ( 1988 ). Essential of biochemistry. Diabet. Med., 5:126.
Henry, R. J. ( 1974 ). Clinical chemistry , principles and Techniques., 2nd ed, Harper and Row, P: 525.
Kobori, H.; Nangaku, M.; Navar, L. G.; Nishiyama, A. ( 2007 ). The intrarenal renin - angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol. Rev., 59(3):251-87.
Young, D. S. ( 2001 ). Effects of disease on clinical lab tests, 4th ed.
Gonen, E. and Rubenstein, A. H. ( 1978 ). AH. Diabetologia, 15:1.
Patton, C. J. and Crouch, S. R. ( 1977 ). Anal. Chem., 49:464- 469.
Doumas, B. T.; Watson, W. A.; Biggs, H. G. ( 1971 ). AlbuminStandards and the measurement of serum albumin with bromcresol green. Clin. Chim. Acta., 31:87-96.
Morgan, G. A.; Leech, N. A.; Gloecner, G. W. and Barrett, K. C. (2010). SPSS for introductory statistic: use and interpretation. 2nd ed. Lawrenz Erlbum associates, publishers Mahwah, New Jersey London .
Satirapoj, B.; Siritaweesuk, N. and Supasyndh, O. ( 2014 ). Urinary Angiotensinogen as a potential biomarker of diabetic nephropathy. Clin. Kidney J., 7: 1-7.
Mills, K. T.; Kobori, H.; Hamm, L. L.; Alper, A. B.; Khan, I. E.; Rahman, M.; Navar, L. G.; Liu, Y.; Browne, G. M.; Batuman, V.; He, J. and Chen, J. ( 2012 ). Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol. Dial. Transplant, 27:3176– 3181.
Rohilla, A.; Tiwari, S. K.; Rohilla, S.; Kushnoor, A. ( 2011 ). Diabetic nephropathy : pathogenesis , prevention and treatment . Pelagia Research Library. Europ. J. Exp. Bio., 1(4):72-80.
Rifkin, D. E.; Katz, R. and Chonchoi, M. ( 2010 ). Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol. Dial. Transplant., 25:1560–1567.
Cheng, Y. W .; Malik, U. and Chang, S. L. ( 2013 ). The risk factors of diabetic nephropathy in Taiwan, including : old age, hypertension and aspirin therapy. Int. J. Diab. Dev. Ctries., 33(2):128.
Vujičić, B.; Turk, T.; Crnčević-Orlić, Ž.; Đorđević , G. and Rački, S. (2012).Diabetic nephropathy.Licensee. In. Tech., 3 : 71-96.
Chen, J.; ( 2014 ). Diabetic nephropathy: scope of the problem. diabetes and kidney disease, ( DOI 10. 1007 / 978 – 1 – 4939 – 0793 - 9_2, © Springer Science Business Media New York.Pp: 9-15.
Ackermann, R. T.; Cheng, Y. J.; Williamson, D. and Gregg, E. W. ( 2011 ) . Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c National Health and Nutrition Examination Survey 2005- 2006 . Am. J. Prev. Med., 40:11–17.
Goud, M. B . K .; Deepa , K .; Sarsina Devi, O., Poornima, M.; Nandini, M. and Asha, K. ( 2010 ). Comparison of blood sorbitol level and microalbuminuria in early detection of diabetic nephropathy in type 2 diabetes. Int. J. Pharma. Bio. Sci., 1( 4 ): 335-339.
Zidane, H. K. and Hammadi, A. M. ( 2013 ). The levels of leptin hormone in patients with non-insulin –dependent diabetes mellitus type II and its relationship with some physiological changes .Journal of University .Babylon / for pure sciences . 21(5) 1540-1547.
Satirapoj, B.; ( 2010 ). Review on pathophysiology and treatment of diabetic kidney disease. J. Med. Assoc. Thai., 93(Suppl. 6): 228– 241.
Jeunemaitre, X.; Soubrier, F.; Kotelevtsev, Y. V. et al. (1992). Molecular basis of human hypertension: role of angiotensinogen. Cell., 71:169–180.
Kobori, H . ; Harrison – Bernard , L . M . and Navar, L. G. ( 2001 ). Enhancement of angiotensinogen expression in angiotensin II- dependent hypertension. Hypertension., 37:1329–1335.
Kobori, H.; Ozawa, Y.; Suzaki, Y. et al. ( 2005 ). Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J. Am. Soc. Nephrol., 16: 2073–2080.
Singh, R.; Singh, A. K.; Leehey, D. J. ( 2005 ). A novel mechanism for angiotensin II formation in streptozotocin – diabetic rat glomeruli.Am. J. Physiol. Renal Physiol., 288:1183–1190.
Suzaki, Y.; Ozawa, Y.; Kobori, H. ( 2007 ). Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats. Int. J. Biol. Sci., 3:40–46.
Liu, F.; Brezniceanu, M. L. and Wei, C. C. ( 2008 ). Overexpression of angiotensinogen increases tubular apoptosis in diabetes. J. Am. Soc. Nephrol., 19: 269–280.
Persson, F.; Lu, X. and Rossing, P. ( 2013 ). Urinary renin and Angiotensinogen in type 2 diabetes : added value beyond urinary albumin?. J. Hypertens., 31:1646–1652.
Kamiyama , M .; Zsombok , A .; Kobori , H . ( 2012 ) . Urinary angiotensinogen as a novel early biomarker of intrarenal renin– angiotensin system activation in experimental type 1 diabetes. J. Pharmacol. Sci., 119:314–323.
Kanalaery, J.; Fenicchia, M.; miller, C.; Ploutz-Synder, L.; Weinstock, R.; Carhart, R. and Azevedo, J. ( 2001 ). Resting serum leptin responses to acute and chronic resistance training in type 2 diabetes men and women. Int. J. Relat. Metab. Disorders., 25 (10): 80-1474.
AL-Daghari, N.; AL-Rubean, K.; Bartlett, W.; AL-Attas, O.; Jones, A. and Kumar, S. ( 2003 ). Serum leptin is elevated in Saudi Arabian patient with metabolic syndrome and coronary artery disease. Diab. Med., 20(10): 832-837.
Fadhil, K. ( 2007 ). Leptin, obesity and type 2 diabetes mellitus in a sample of postmenopausal Iraqi women. University of Baghdad / Collage of medicine / physiological Chemistry Department. Master thesis.
Cnop, M.; Landchild, M.; Vidal, J.; Havel, P.; Knowles, N.;Carr, D.; Wang, F.; Hull, R.; Boyko, E.; Retzlaff, B.; Walden, C.; Knopp, R. and Kahn, S. ( 2002 ). The concurrent accumulation of intra- abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations distinct metabolic effects of two fat compartments. Diabetes., 51:1005–15.
Considine, R.; Sinha, M.; Heiman, M.; Kriauciunas, A. Stephens, T.; Nyce, M.; Ohannesian, J.; Marco, C.; McKee, L. and Bauer, T. ( 1996 ). Serum immune reactive- leptin concentrations in normal- weight and obese humans. N. Engl. J. Med., 334:292-5.
Rosenbaum, M.; Nicolson, M.; Hirsch, J.; Heymseld, S.; Gallagher, D.; Chu, F. and Leibel, R. (1996). Effect of gender, body composition, menopause on plasma concentrations of leptin. J. Clin. Endocrinol. Metab., 81:3424-3427.
AL-Maskari, M.; Waly, M.; Ali, A. and Al-Shuaibi, Y. (2011). Dietary pattern and serum leptin in patients with type 2 diabetes mellitus in Oman: a case-control study. The FASEB Journal., 25:995-1013.
Jonsson, J. R.; Game, P. A.; Head, R. J. and Frewin, D. B. (1994). The expression and localization of the angiotensin-converting enzyme mRNA in human adipose tissue. Blood . Pressure ., 3:72 - 75.
Schwartz, M. and Gelling, R. ( 2002 ). Rats lighten up with MCH antagonist. Nature Med., 8(8):779-782.
Katsiki, N.; Mikhailidis, D.; Gotzamani-Psarrakou, A.; Didangelos, T.; Yovos, J. and Karamitsos, D. ( 2011 ). Effects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptide levels in patients with type 2 diabetes mellitus: a Pilot Study. The Open . Cardiovas. Med. J., 5:136- 147.
Myers, B. (2002) . Disease management programs are strongly recommended to improve diabetes care. Am. J. Prev. Med., 22(4): 15-38.
merican Diabetes Association. (1993). Screening for diabetes. Diabetes . Care (suppl. II). ,16:7-9.
Hussain, A. F. and et al. ( 2012 ). Study of the level of some lipids and fatty proteins in diabetic patients (type 2) in alkadisya governorate . University of Karbala. P: 135-146.
-Rands, V. F.; Seth, D. M.; Kobori, H. and Prieto, M. C. (2012). Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II–salt hypertension. Gend. Med., 9(4): 207–218.
Osterby, R.; Parving, H. H. and Hommel, E. ( 1990 ). Glomerular structure and function in diabetic nephropathy. Diabetes., 39:1057-1063.
Guyton, A. G. and Hall J. E. (2006). Textbook of medical of physiology.11th ed. Philadelphia, Pennsylvania, Elsevier Saunders. Pp:
-359.
Bal, W.; Sokołowska, M.; Kurowska, E. and Faller, P. (2013). Binding of transition metal ions to albumin: sites, affinities and rates. Biochim. Biophys. Acta.,1830:5444–5455.
Kamiyama, M.; Urushihara, M.; Morikawa, T., et al. ( 2013 ). Oxidative Stress / angiotensinogen / renin–angiotensin system axis in patients nephropathy. Int. J. Mol. Sci., 14:23045–23062.
Kobori, H. ; Kamiyama, M.; Harrison-Bernard, L. M.; Navar, L. G. ( 2013 ). Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy. J. Investig. Med., 61: 256–264.
Abdul Hussein, M. A. ( 2012 ). Validity of HbA1c for screening and diagnosis of diabetes mellitus. Kufa Med. J., 15(1):223-231.
Nakagami, T.; Tominaga, M.; Nishimura, R.; Yoshiike, N.; Daimon, M.; Oizumi, T.; Tajima, N. (2007). Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes?. Japan national diabetes survey. Diabet . Res. Clin. Pract., 76:251–256.
Droumaguet, C.; Balkau, B.; Simon, D.; Caces, E.; Tichet, J.; Charles, M. A. and Eschwege, E. (2006). Use of HbA1c in predicting progression to diabetes in French men and women : data from an epidemiological study on the insulin resistance syndrome (DESIR). Diabetes. Care., 29:1619–1625.
Shirasaya, K.; Miyakawa, M.; Yoshida, K.; Takahashi, E.; Shimada, N.; Kondo, T.( 1999 ). Economic evaluation of alternative indicators for screening for diabetes mellitus. Prev. Med., 29:79–78.
-Moussa, A. and Romanlan, J. ( 2008 ). Oxidative stress in diabetes mellitus. Biophys. , 18(3): 225-236.
Kilpatrick, E. ( 2000 ). Glycosylated hemoglobin in the tear. J. Clin. Pathol., 53(5): 335-339.
Smith, A . F .; Beckett, G. J.; Walker, S. W. and Rac, P. W. (1998). Clinical biochemistry 6th ed, Blackwell Science.
Tyagi, U.; Agrawal, V.; Amitabh, A. K.; Jain, S. and Saxena. (2008). Thickness of glomerular and tubular basement membranes in preclinical and clinical stages of diabetic nephropathy. Indian. J. Nephrol., 18(2):64-69.
Viswanathan, V.; Tilak, P. and Kumpatla, S. ( 2012 ). Risk factors associated with the development of overt nephropathy in type 2 diabetes patients : A 12 year's observational study. Indian. J. Med. Res., 136:46-53.
Boon, N. A.; Colledge, N. R. and Walker, B. R. (2006). Davidson's principles & practice of medicine. 20th ed. Churchill,
Livingstone, Elsevier., Pp: 808-843.
Singh , R . and et al . ( 2008 ) . Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats. Translation.Res.,151(4):208-216.
Bhonsle , H. S.; Korwar , A. M.; Kote , S. S.; Golegaonkar , S. B.; Chougale , A. D.; Shaik , M. L.; Dhande , N. L.; Giri , A. P.; Shelgikar , K. M.; Boppana, R. and Kulkarni, M. J. (2012). Low plasma albumin levels are associated with increased plasma protein glycation and HbA1c in diabetes. J. Proteome. Res., 11(2):1391–1396.
Abass, M. K. and Salman, A. M. A. ( 2010 ). Estimation the ways of Diagnosis diabetes mellitus and the effect of its complications on the kidney. Engineer. Technol. J. ,28(18): 907-923.
Hussain, F.; Sheikh, M. A.; Maan, M. A.; Nawaz, H. and Jamil, A. ( 2010 ). Plasma protein glycation in diabetic nephropathy. Pak. J. Biochem. Mol. Biol., 43(2): 85-89.
Bosman, D. R.; Winkler, A. S.; Marsden, J. T.; Macdougall, I. C. and Watkins, P. J. ( 2001 ). Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabet. Care., 24(3): 495-499.
Shahid, S. M. and Mahboob, T. ( 2006 ). Clinical correlation between frequent risk factors of diabetic nephropathy and serum sialic acid. Int. J. Diabet. Metabol., 14:138-142.
Idonije, B. O.; Festus, O. and Oluba, O. M. ( 2011 ). Plasma glucose , creatinine and urea levels in Type 2 diabetic patients attending a Nigerian teaching hospital. Res. J. Med. Sci., 5(1):1-3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Eman A. Mohammad, Saher Mahmood Jwad
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
